108.80 -0.03 (-0.03%)
After hours: 6:21PM EDT
|Bid||108.80 x 1000|
|Ask||108.68 x 900|
|Day's range||105.74 - 109.48|
|52-week range||61.61 - 114.20|
|Beta (5Y monthly)||0.95|
|PE ratio (TTM)||62.87|
|Forward dividend & yield||1.44 (1.37%)|
|Ex-dividend date||14 Oct 2020|
|1y target est||N/A|
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Abbott Laboratories (ABT) on Behalf of Investors
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Abbott Laboratories.
The Law Offices of Frank R. Cruz announces an investigation on behalf of Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT) investors concerning the Company and its officers’ possible violations of federal securities laws.